OSAKA, Japan — (BUSINESS WIRE) — Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (「Takeda」) today announced that it has entered into an agreement to divest a portfolio of select non…
Takeda Divests Select Non-Core Assets in Europe to Cheplapharm for Approximately $562 million USD
OSAKA, Japan — (BUSINESS WIRE) — Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (「Takeda」) today announced that it has entered into an agreement to divest a portfolio of select non…